Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform
Start Date
2/3/2026
Completion Date
1/1/2036
Summary
The WILLEM Registry is a large-scale, single-group, observational, registry study to collect continuous clinical evidence of Willem in real-world settings. Cardiovascular diseases are a major problem for public health and healthcare systems. Electrocardiograms (ECGs) are simple tests which increase diagnostic performance and early detection of cardiovascular diseases. However, its interpretation is complex, time consuming for cardiology experts, and entails high costs for healthcare systems. Willem allows AI-based automatic interpretation and its performance has been examined in previous clinical trials, but additional clinical evidence is needed for its integration in real-world clinical settings. This study will collect clinical evidence of Willem performance to detect cardiac abnormalities in ECGs from high-risk cardiac patients admitted to cardiovascular units.
Detailed Description
Patient enrollment will be both retrospective and prospective.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Willem AI ECG assessment
Conditions
Locations
Vanderbilt University Medical Center
Nashville, Tennessee 37232
United States
CardioHeredia
Guayaquil, Guayas 090101 - 090158
Ecuador
La Paz University Hospital
Madrid, 28046
Spain
Puerta de Hierro University Hospital
Madrid, 28222
Spain
Murcia University
Murcia, 30100
Spain